Tove Cecilie Viebe
Founder & CMO
MD, Executive Master of Management, BI Norwegian Business School
Viebe is the founder and has served AS CEO of SEALD. She is a specialist in general surgery focusing on gastrointestinal surgery. Viebe holds an MBA from BI Norwegian Business School and is a former senior consultant at the Department of Cancer and Surgery, Oslo University Hospital, and within palliative care at Hospice Lovisenberg. Viebe established and ran the Biotech 2010 and 2011 conferences on commercialisation of medical research. The conferences were among the biggest in Northern Europe in their field.
firstname.lastname@example.org – (+47) 91315131
Clinical Project Director
Paul Gordon is former senior researcher at the Department of Tissue Culture at The Cancer Research Institute, the Norwegian Radium Hospital, with a Dr. Philos degree centered around liver cells. He has more than 25 years experience as clinical project director and medical director at the clinical department of Nycomed (later Nycomed Amersham and finally GE Healthcare) and also clinical project director by Mentis Cura AS.
Chief Data Officer
Dr. Rer. Nat, Ph.D Molecular biology
Stangeland is professor competent Chief Data Scientist and Managing Solution Architect with over 25 years of academic research, such as Oslo University Hospital and the University of Oslo. She focused on use of machine learning and analytics to create value for organizations and companies. Her core skills include molecular biology, bioinformatics, machine learning, privacy regulations, strategic work and commercialization.
Quality Assurance Manager
Msc Mechanical Engineering
Lucile Souzy helds a Master’s degree of Mechanical and Design Engineering – INSA Lyon and BAI–BA Mechanical & Manufacturing Engineering, Bioengineering option – Trinity College of Dublin, Ireland. Souzy´s main area is to implement, maintain and improve quality management systems (QMS). At Seald her responsibilities is Device classification & regulatory strategy, audits/gap analysis (MDR, QMS, Usability, Software, Risk). At Seald she is working in close cooperation with our preferred Clinical Research Organisation and Clinical Project Director (to be announced).
Chief Executive Officer
To Be Announced
Chief Financial Officer
To Be Announced
Ove V. Solesvik
Business Development Advisor
Solesvik has more than 30 years of national and international experience with research-, technology- and innovation based business development and management, with main focus on Health and Life Sciences, including medical devices and E-health. He has extensive management experience from both public and private sector.